10.2 Case Follow-up and Review
Key Takeaways
- Reassessment must occur at planned intervals (commonly every 2 weeks or every 4-12 visits) using objective, repeatable measures compared against a documented baseline
- The continue/change/stop decision is driven by the trend in objective findings relative to expected timelines, not by patient request alone or by visit count alone
- Validated outcome measures (VAS/NRS, Oswestry Disability Index, Neck Disability Index, Patient-Specific Functional Scale, Global Rating of Change) provide the objective basis for reassessment
- A lack of meaningful improvement after a reasonable trial of care (typically 2-4 weeks or 6-12 visits) requires the plan to be modified, the diagnosis reconsidered, or the patient referred - not simply continued unchanged
- New or worsening red-flag findings at any reassessment point override the existing plan and require immediate action, regardless of where the patient is in the treatment course
Case Follow-up and Review
Quick Answer: Follow-up care is not simply repeating the initial treatment - it requires scheduled reassessment against objective outcome measures, followed by a deliberate decision to continue, modify, or discontinue care. NBCE Part III vignettes commonly present a patient at a reassessment point and ask what the doctor should do next based on the trend in the data, not the raw current symptom level alone.
When and Why to Reassess
Reassessment should be built into the treatment plan from the outset, not triggered only when a patient fails to improve. Common reassessment triggers include:
- Scheduled intervals - e.g., every 2 weeks, or after a defined number of visits (commonly 4, 6, or 12 visits depending on condition severity)
- End of a care phase - transitioning from relief to corrective care, or corrective to supportive care
- Plateau or lack of expected progress - symptoms or function stop improving despite continued care
- New symptoms or a change in clinical presentation - any new complaint, neurological change, or red flag
- Patient-reported worsening - regardless of where this falls in the planned schedule
At each reassessment, findings must be compared to the documented baseline recorded at the initial visit. Without a baseline, no meaningful comparison is possible, which is why thorough initial documentation (see Section 10.4) is a prerequisite for defensible follow-up.
Objective Outcome Measures
Outcome measures give reassessment a quantifiable, reproducible basis rather than relying on subjective impressions alone.
| Outcome Measure | What It Assesses | Common Use |
|---|---|---|
| Visual Analog Scale (VAS) / Numeric Rating Scale (NRS) | Current pain intensity (0-10 or 0-100mm) | Any condition; tracked at every visit or reassessment |
| Oswestry Disability Index (ODI) | Functional disability from low back pain | Low back conditions |
| Neck Disability Index (NDI) | Functional disability from neck pain | Cervical spine conditions |
| Patient-Specific Functional Scale (PSFS) | Patient-identified functional activities and their limitation | Any musculoskeletal condition, individualized |
| Global Rating of Change (GROC) | Patient's overall perceived change since baseline | Supplemental measure at reassessment |
| Range of motion (goniometry/inclinometry) | Objective joint mobility | Spinal and extremity conditions |
| Orthopedic/neurological test findings | Objective sign changes (e.g., SLR angle, reflex, sensory findings) | Conditions with a positive baseline finding |
A meaningful clinical improvement is typically defined as a change exceeding the minimal clinically important difference (MCID) for the given instrument - a small numeric change within measurement error should not be interpreted as clinically meaningful improvement.
The Continue / Change / Stop Decision Framework
At each reassessment point, the clinical response should be categorized, and the plan updated accordingly:
| Clinical Response | Interpretation | Appropriate Action |
|---|---|---|
| Improving as expected | Progressing toward stated goals on schedule | Continue current plan; proceed toward phase transition or discharge |
| Improving, slower than expected | Some progress, not on the projected timeline | Modify plan - adjust frequency, add or change adjunctive care, extend timeline with documented justification |
| Plateaued | No meaningful change across two or more consecutive reassessments | Reconsider the working diagnosis, change the treatment approach, or refer if a prior modification already failed |
| No improvement after a reasonable trial | No meaningful change from baseline after roughly 2-4 weeks or 6-12 visits | Discontinue the current approach; reconsider diagnosis; referral strongly considered |
| Worsening | Symptoms, function, or objective findings decline | Stop or substantially alter current care; re-screen for red flags; refer as indicated |
| New red flags at any point | Findings suggest a serious or non-musculoskeletal condition | Stop manual care immediately; refer urgently (see Section 10.3) |
The "reasonable trial" concept is central to defensible case management: conservative care is expected to produce objectively measurable improvement within a bounded period. Continuing an unmodified plan indefinitely in the absence of that improvement - simply because the patient tolerates it or requests it - is not clinically supportable and is a common wrong-answer trap in exam vignettes.
Maximum Therapeutic Benefit and Discharge
A patient reaches maximum therapeutic benefit (MTB) when objective measures plateau and further care is not expected to produce additional meaningful improvement. MTB is distinct from full resolution: a patient can reach MTB with residual findings (e.g., mild persistent stiffness) if repeated trials of modified care produce no further gains. At MTB, appropriate next steps include:
- Discharge to self-management - home exercise, activity modification, education on recurrence prevention
- Transition to supportive/wellness care - only when a documented history of recurrence or an underlying chronic/degenerative condition justifies periodic visits
- Referral - when residual findings suggest a condition outside the scope or effectiveness of chiropractic care alone
Documenting the Reassessment
Each reassessment note should explicitly state: the outcome measure(s) used, the current value compared to baseline and the prior reassessment, the clinical interpretation of that trend, and the resulting decision (continue, modify, discharge, or refer) with rationale. This creates the audit trail that demonstrates care was continuously justified by objective findings rather than delivered on autopilot - a standard that applies equally to clinical defensibility and third-party payer review of medical necessity.
A patient shows no meaningful change in Oswestry Disability Index score across two consecutive reassessments despite 8 visits of unmodified conservative care over 4 weeks. What is the most appropriate next step?
Which outcome measure is specifically designed to assess functional disability related to low back pain?
A patient at maximum therapeutic benefit (MTB) still has mild residual stiffness that has not changed across the last two reassessments despite a modified treatment approach. What does this most likely indicate?